Xiaofeng Zhai

2.8k total citations
73 papers, 2.0k citations indexed

About

Xiaofeng Zhai is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Xiaofeng Zhai has authored 73 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 16 papers in Cancer Research and 12 papers in Infectious Diseases. Recurrent topics in Xiaofeng Zhai's work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cancer-related molecular mechanisms research (10 papers) and Cancer Mechanisms and Therapy (8 papers). Xiaofeng Zhai is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cancer-related molecular mechanisms research (10 papers) and Cancer Mechanisms and Therapy (8 papers). Xiaofeng Zhai collaborates with scholars based in China, United States and Estonia. Xiaofeng Zhai's co-authors include Shuo Su, Changquan Ling, Michael Veit, Jiyong Zhou, Wan-Ting He, Jiumeng Sun, Gairu Li, Marc A. Suchard, Xiang Ji and Alexander Lai and has published in prestigious journals such as Nature Communications, Cancer and Journal of Virology.

In The Last Decade

Xiaofeng Zhai

70 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofeng Zhai China 25 638 485 305 288 197 73 2.0k
Ying Xue China 25 666 1.0× 409 0.8× 124 0.4× 423 1.5× 125 0.6× 99 2.2k
Kai Lü China 25 742 1.2× 839 1.7× 275 0.9× 278 1.0× 80 0.4× 85 2.5k
Yi‐Ming Arthur Chen Taiwan 29 1.0k 1.6× 1.1k 2.3× 281 0.9× 512 1.8× 143 0.7× 113 2.8k
Xiaofang Zhao China 19 488 0.8× 909 1.9× 231 0.8× 342 1.2× 93 0.5× 58 2.2k
Qing Chang China 30 1.3k 2.1× 857 1.8× 340 1.1× 233 0.8× 163 0.8× 128 3.4k
Jing Lu China 28 774 1.2× 1.1k 2.2× 127 0.4× 524 1.8× 157 0.8× 124 2.5k
Andrés López‐Cortés Ecuador 22 712 1.1× 640 1.3× 239 0.8× 109 0.4× 61 0.3× 104 2.0k
Anna Ruggieri Italy 23 690 1.1× 412 0.8× 435 1.4× 771 2.7× 70 0.4× 50 2.0k
Yuan Huang China 18 1.2k 1.9× 1.2k 2.6× 297 1.0× 278 1.0× 137 0.7× 42 2.8k
Heike Schneider Germany 19 744 1.2× 1.0k 2.1× 247 0.8× 294 1.0× 192 1.0× 25 2.2k

Countries citing papers authored by Xiaofeng Zhai

Since Specialization
Citations

This map shows the geographic impact of Xiaofeng Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Zhai more than expected).

Fields of papers citing papers by Xiaofeng Zhai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Zhai. The network helps show where Xiaofeng Zhai may publish in the future.

Co-authorship network of co-authors of Xiaofeng Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Zhai. A scholar is included among the top collaborators of Xiaofeng Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Zhai. Xiaofeng Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
5.
6.
Zhang, Jinbo, Yuqian Wang, Shufang Liang, et al.. (2024). Jiedu recipe, a compound Chinese herbal medicine, suppresses hepatocellular carcinoma metastasis by inhibiting the release of tumor-derived exosomes in a hypoxic microenvironment. Journal of Integrative Medicine. 22(6). 696–708. 10 indexed citations
7.
Zhai, Xiaofeng, Xiaoling Li, Michael Veit, et al.. (2024). LDLR is used as a cell entry receptor by multiple alphaviruses. Nature Communications. 15(1). 622–622. 19 indexed citations
8.
Wang, Yu, Chang Zhang, Dongyan Li, et al.. (2023). Transmission of HCoV-OC43 to pet hamsters. Microbial Pathogenesis. 185. 106364–106364. 1 indexed citations
9.
10.
Pan, Bo, et al.. (2023). Acceptance and attitude towards the traditional chinese medicine among asymptomatic COVID-19 patients in Shanghai Fangcang hospital. BMC Complementary Medicine and Therapies. 23(1). 97–97. 6 indexed citations
11.
Ding, Jie, et al.. (2022). Identifying the Mechanism of Polygoni Cuspidati Rhizoma et Radix in Treating Acute Liver Failure Based on Network Pharmacology and Molecular Docking. Gastroenterology Research and Practice. 2022. 1–14. 4 indexed citations
12.
Li, Min, Yuxiao Tang, Dongyao Wang, et al.. (2021). Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma. Molecular Therapy. 30(2). 703–713. 33 indexed citations
13.
Sun, Jiumeng, Wan-Ting He, Lifang Wang, et al.. (2020). COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives. Trends in Molecular Medicine. 26(5). 483–495. 434 indexed citations
14.
Zhai, Xiaofeng, Xiaolin Liu, Feng Shen, Jia Fan, & Changquan Ling. (2018). Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma: A randomized controlled study. Cancer. 124(10). 2161–2168. 53 indexed citations
15.
Zhai, Xiaofeng, et al.. (2017). Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression.. PubMed Central. 9(1). 155–166. 28 indexed citations
16.
Zhai, Xiaofeng, et al.. (2017). Classifier of cross talk genes predicts the prognosis of hepatocellular carcinoma. Molecular Medicine Reports. 16(3). 3253–3261. 8 indexed citations
17.
Zhai, Xiaofeng, et al.. (2017). Colon cancer recurrence-associated genes revealed by WGCNA co-expression network analysis. Molecular Medicine Reports. 16(5). 6499–6505. 99 indexed citations
18.
Ling, Chen, Yinglu Feng, Yani Zhang, et al.. (2015). Prevalence of neutralizing antibodies against liver-tropic adeno-associated virus serotype vectors in 100 healthy Chinese and its potential relation to body constitutions. Journal of Integrative Medicine. 13(5). 341–346. 28 indexed citations
19.
Zhai, Xiaofeng, et al.. (2014). Hippocampal UCP2 is essential for cognition and resistance to anxiety but not required for the benefits of exercise. Neuroscience. 277. 36–44. 15 indexed citations
20.
Zhai, Xiaofeng, Zhe Chen, Bai Li, et al.. (2013). Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial. Journal of Integrative Medicine. 11(2). 90–100. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ying Xue Breakdown of academic impact, for papers by Kai Lü Breakdown of academic impact, for papers by Yi‐Ming Arthur Chen Breakdown of academic impact, for papers by Xiaofang Zhao Breakdown of academic impact, for papers by Qing Chang Breakdown of academic impact, for papers by Jing Lu Breakdown of academic impact, for papers by Andrés López‐Cortés Breakdown of academic impact, for papers by Anna Ruggieri Breakdown of academic impact, for papers by Yuan Huang Breakdown of academic impact, for papers by Heike Schneider
Rankless by CCL
2026